Analysts surveyed by Thomson Reuters expect the third-largest U.S. drugstore chain to earn net income of $52.5 million, or 5 cents a share, and revenue of $6.43 billion over its May-ended quarter. Over the same period a year earlier, the company earned $91 million, or 9 cents a share, and generated sales of $6.3 billion.
A quarter earlier, Rite Aid recorded net income of 6 cents a share and revenue of $6.6 billion. Analysts surveyed had anticipated net income of 4 cents a share and revenue of $6.54 billion.
Must read: Warren Buffett's 25 Favorite Stocks
Separately, TheStreet Ratings team rates RITE AID CORP as a Hold with a ratings score of C. TheStreet Ratings Team has this to say about their recommendation:
"We rate RITE AID CORP (RAD) a HOLD. The primary factors that have impacted our rating are mixed -- some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance for this stock relative to most other stocks. The company's strengths can be seen in multiple areas, such as its revenue growth and solid stock price performance. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income, poor profit margins and weak operating cash flow."